
Cytokinetics, Incorporated CYTK
$ 62.07
-4.98%
Annual report 2025
added 02-26-2026
Cytokinetics, Incorporated P/B Ratio 2011-2026 | CYTK
Annual P/B Ratio Cytokinetics, Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.0114 | -0.0391 | -0.0184 | -0.036 | 0.0144 | 0.0118 | -67.7 | 14.6 | 4.14 | 4.25 | 4.36 | 2.75 | 4.02 | 1.71 | 1.53 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.6 | -67.7 | -2.03 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.58 | $ 21.66 | 1.14 % | $ 1.01 B | ||
|
I-Mab
IMAB
|
1.12 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
0.485 | $ 0.9 | -0.2 % | $ 6.62 M | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
4.36 | $ 22.33 | 1.66 % | $ 3.7 B | ||
|
Esperion Therapeutics
ESPR
|
-1.86 | $ 1.94 | 1.31 % | $ 403 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | ||
|
Galectin Therapeutics
GALT
|
-1.41 | $ 2.38 | 2.33 % | $ 152 M | ||
|
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | ||
|
Greenwich LifeSciences
GLSI
|
45.4 | $ 24.07 | -0.58 % | $ 313 M | ||
|
Heron Therapeutics
HRTX
|
13.8 | $ 1.18 | -0.84 % | $ 197 M | ||
|
ImmuCell Corporation
ICCC
|
2.15 | $ 8.26 | -1.07 % | $ 74.6 M | ||
|
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | ||
|
InflaRx N.V.
IFRX
|
1.41 | $ 1.61 | 8.78 % | $ 152 M | ||
|
Allakos
ALLK
|
0.674 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-0.258 | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
Innate Pharma S.A.
IPHA
|
1.36 | $ 1.39 | 0.72 % | $ 235 M | ||
|
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | ||
|
Inventiva S.A.
IVA
|
6.02 | $ 5.11 | -0.78 % | $ 138 M | ||
|
Jaguar Health
JAGX
|
-0.0512 | $ 0.29 | -25.25 % | $ 676 K | ||
|
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.815 | - | -2.5 % | $ 5.88 M | ||
|
Applied Therapeutics
APLT
|
-31.5 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | ||
|
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-0.17 | - | 17.91 % | $ 11.1 M | ||
|
KalVista Pharmaceuticals
KALV
|
-308 | $ 19.09 | -2.75 % | $ 1.03 B | ||
|
BioNTech SE
BNTX
|
5.29 | $ 102.36 | -2.94 % | $ 27.2 B | ||
|
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-13.9 | $ 4.11 | 0.61 % | $ 439 M | ||
|
Arcutis Biotherapeutics
ARQT
|
18.2 | $ 23.18 | -0.34 % | $ 2.95 B | ||
|
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.81 | $ 1.43 | -0.7 % | $ 381 M | ||
|
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | ||
|
AstraZeneca PLC
AZN
|
2.07 | - | - | $ 96.9 B | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
2.67 | $ 240.72 | 4.09 % | $ 4.4 B | ||
|
AVROBIO
AVRO
|
0.594 | - | 1083.1 % | $ 745 M | ||
|
Eli Lilly and Company
LLY
|
8.36 | $ 874.81 | -1.06 % | $ 785 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 2.9 | -0.34 % | $ 4.77 M | ||
|
BioDelivery Sciences International
BDSI
|
1.64 | - | -4.8 % | $ 255 M |